Empowered Antibody Therapies - IBC conference.
The Empowered Antibody Therapies conference, held in Burlingame, CA, USA, included topics covering new therapeutic developments in the field of multispecific antibodies. This conference report highlights selected presentations on DVD-Igs from Abbott Laboratories, ImmTACs from Immunocore, 'Dock-and-Lock' technology from Immunomedics, the bispecific BiTE antibody blinatumomab from Micromet, and Triomabs from TRION Pharma and Fresenius Biotech.
Herold
Jens
J
TRION Pharma, Frankfurter Ring 193a, 80807 Munich, Germany. jens.herold@trionpharma.de
D000818:Animals; D000906:Antibodies / Q000235:genetics*; D018033:Antibodies, Bispecific / Q000494:pharmacology / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D015507:Drugs, Investigational / Q000494:pharmacology; D006801:Humans; D007116:Immunization, Passive; D051379:Mice; D058990:Molecular Targeted Therapy; D051381:Rats
D000906:Antibodies; D018033:Antibodies, Bispecific; D015507:Drugs, Investigational; C510808:blinatumomab